224 related articles for article (PubMed ID: 18701846)
1. [Evaluation of short-time premedication with d-chlorpheniramine maleate injection for paclitaxel-induced hypersensitivity reaction].
Harada T; Doi M; Yamada Y; Akase T
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1347-51. PubMed ID: 18701846
[TBL] [Abstract][Full Text] [Related]
2. [Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma].
Komatsubara K; Miyoshi K; Kogure Y; Matsuhisa T; Eguchi H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):107-10. PubMed ID: 20087041
[TBL] [Abstract][Full Text] [Related]
3. Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
Bookman MA; Kloth DD; Kover PE; Smolinski S; Ozols RF
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-13-S19-15. PubMed ID: 9427258
[TBL] [Abstract][Full Text] [Related]
4. A simplified premedication schedule for 1-hour paclitaxel administration.
Tsavaris N; Kosmas C; Vadiaka M
J Support Oncol; 2005; 3(1):77-81. PubMed ID: 15724950
[TBL] [Abstract][Full Text] [Related]
5. Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.
Braverman AS; Rao S; Salvatti ME; Adamson B; McManus M; Pierre S
Chemotherapy; 2005 May; 51(2-3):116-9. PubMed ID: 15886470
[TBL] [Abstract][Full Text] [Related]
6. A simplified premedication protocol for one-hour paclitaxel infusion in various combinations.
Kosmas C; Tsavaris N
Med Sci Monit; 2006 Nov; 12(11):CR462-6. PubMed ID: 17072270
[TBL] [Abstract][Full Text] [Related]
7. Single-dose dexamethasone paclitaxel premedication.
Micha JP; Rettenmaier MA; Dillman R; Fraser P; Birk C; Brown JV
Gynecol Oncol; 1998 May; 69(2):122-4. PubMed ID: 9600818
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel.
Kwon JS; Elit L; Finn M; Hirte H; Mazurka J; Moens F; Trim K
Gynecol Oncol; 2002 Mar; 84(3):420-5. PubMed ID: 11855881
[TBL] [Abstract][Full Text] [Related]
9. Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions.
Sasada S; Hirashima T; Nakamura Y; Takimoto T; Furukawa M; Kobayashi M; Nitta T; Matsui K; Kawase I
Int J Clin Oncol; 2007 Aug; 12(4):274-8. PubMed ID: 17701006
[TBL] [Abstract][Full Text] [Related]
10. A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care.
Milani A; De Pas T; Noberasco C; McDonnell C; Libutti L; Limardi I; Zencovich C; Boselli S; Bianchi M; de Braud F
Lung Cancer; 2007 Nov; 58(2):300-1. PubMed ID: 17881082
[TBL] [Abstract][Full Text] [Related]
11. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].
Ouchi A; Ouchi A; Asano M; Aono K; Watanabe T; Kato T
Gan To Kagaku Ryoho; 2014 Jul; 41(7):889-91. PubMed ID: 25131878
[TBL] [Abstract][Full Text] [Related]
12. Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy.
Parinyanitikul N; Tanpipattanakul W; Poovorawan N; Rattananupong T; Laoitthi P; Sithidetphaiboon P; Thanasanvimon S; Sriuranpong V
Support Care Cancer; 2018 Jul; 26(7):2471-2477. PubMed ID: 29435713
[TBL] [Abstract][Full Text] [Related]
13. A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors.
Zhang Q; Huang XE; Gao LL
Biomed Pharmacother; 2009 Sep; 63(8):603-7. PubMed ID: 19019625
[TBL] [Abstract][Full Text] [Related]
14. Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.
Köppler H; Heymanns J; Weide R
Onkologie; 2001 Jun; 24(3):283-5. PubMed ID: 11455223
[TBL] [Abstract][Full Text] [Related]
15. [A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus -about the control of blood glucose when dexamethasone for prophylaxis against paclitaxel-associated hypersensitivity reactions to the diabetic has been administered].
Yoshizawa Y; Goto T; Matsubara T; Maezawa K; Mizukami H; Saito M; Nemoto H; Sasaya S; Sanada Y
Gan To Kagaku Ryoho; 2008 Apr; 35(4):641-4. PubMed ID: 18408435
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of paclitaxel for gastric cancer is AUC dependent].
Yamada T; Tanaka N; Furukawa K; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Ohaki Y; Tajiri T
Gan To Kagaku Ryoho; 2008 Feb; 35(2):251-3. PubMed ID: 18281760
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions.
Kennedy LD; Case LD; Hurd DD; Cruz JM; Pomper GJ
Transfusion; 2008 Nov; 48(11):2285-91. PubMed ID: 18673350
[TBL] [Abstract][Full Text] [Related]
18. Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Berger MJ; Vargo C; Vincent M; Shaver K; Phillips G; Layman R; Macrae E; Mrozek E; Ramaswamy B; Wesolowski R; Shapiro CL; Lustberg MB
Support Care Cancer; 2015 Jul; 23(7):2019-24. PubMed ID: 25519756
[TBL] [Abstract][Full Text] [Related]
19. Oral premedication for the prevention of hypersensitivity reactions to paclitaxel.
Zidan J; Hussein O; Abzah A; Tamam S; Farraj Z; Friedman E
Med Oncol; 2008; 25(3):274-8. PubMed ID: 18363113
[TBL] [Abstract][Full Text] [Related]
20. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
